Autoimmune and inflammatory diseases are conditions where the body's immune system mistakenly attacks its own tissues, leading to inflammation and tissue damage. In a healthy immune system, specialized cells and molecules work together to recognize and destroy foreign invaders like bacteria and viruses while leaving the body's own cells unharmed. However, in autoimmune diseases, this self-recognition mechanism malfunctions, causing the immune system to target healthy cells, tissues, and organs. There are over 80 known autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, and inflammatory bowel diseases like Crohn's disease and ulcerative colitis. Each autoimmune disease has its own specific set of symptoms and targets different parts of the body. Inflammatory diseases, on the other hand, involve the body's response to injury, infection, or irritation. Inflammation is a natural and necessary process for healing, as it helps the body to remove harmful stimuli and initiate tissue repair. However, chronic inflammation can occur when the immune system is constantly activated, leading to tissue damage and contributing to various diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases. Both autoimmune and inflammatory diseases can have significant impacts on an individual's quality of life and may require long-term management and treatment to control symptoms and prevent complications. Treatment approaches often involve medications to suppress the immune response, alleviate inflammation, and manage symptoms, along with lifestyle modifications such as diet and exercise.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom